MPTRVT

Biocard™ Rapid test for HCV antibodies is developed based on Antibody sandwich by Lateralflow immunochromatography assay for the qualitative detection of antibodies to HCV infection by using Core, NS3, NS4 and NS5 Antigens.All the accessories needed for the sampling and testing are included.Works on Serum/Plasma and Whole Blood.Results can be obtained in 20 minutes.

Labsystems Diagnostics’ Bordetella pertussis EIA tests

• Pertussis toxin (PT) is a specific antigen for the detection of Bordetella pertussis, the use of PT is also recommended by the European guidelines (European Center for the Disease Prevention and Control)
• Whole cell antigen tests also available
• The kits come with ready-to-use, well sufficient reagents and breakable, coded strips.
• IgG Remover (RF absorbent) is included in the IgM kits, no separate reagents or steps are needed.
• The kits are suitable for different automatic systems and manual testing.
• Multi-testing with other LDx tests is easy due to interchangeable reagents, like buffers and substrate, and similar test procedures.
• Internal and external quality monitoring maintain constant quality

Labsystems Diagnostics’ Neonatal Toxoplasma gondii IgM FEIA is a fluorometric enzyme immunoassay intended for the determination of IgM-class antibodies to Toxoplasma gondii in blood samples dried on filter paper. The test is intended as a primary method for screening newborns for congenital toxoplasmosis (CT).

Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency is the most common human enzyme deficiency; an estimated 400 million people worldwide are affected by this enzymopathy (6). With regards to the demographics of G6PD deficiency, most of the affected individuals reside in Africa, the Middle East, and Southeast Asia. The G6PD enzyme catalyzes an oxidation/reduction reaction.

Cystic Fibrosis (CF) is an autosomal recessive disorder affecting the lungs, pancreas, intestine and liver. CF is the most common in Caucasians with an incidence rate 1:2500 newborns. CF is caused by mutation in the gene for the protein cystic fibrosis transmembrane conductance regulator (CTFR) [1,2]. Large-scale neonatal screening for CF is performed by indentification of increased levels of immunoreactive trypsinogen (IRT) in blood.

1.Compact Design

2. Quantitative UPLC – MS/MS applications

3. Rapid, reliable and reproducible quantitative data for the clinical laboratory

4. Clinical laborataries have access to the selectively, sensitivity and versatility of LC-MS

5. Reduces complexity and maximizes throughput and uptime

6. The system is controlled by Mass Lynx IVD Software